Capital & conviction report: Australian healthtech funding FY26

The headline number for Australian healthtech funding is easy to find. The story underneath it is harder. So we mapped it from two sides: a full year of FY2026 deal flow, and the 131 investors who have backed the sector since 2020. Both in one report.

The short version: $2.8b went into the sector in FY2026, but a single acquisition was 57% of that. Strip it out and the real market is closer to $1.2b. The busiest funders are not the venture brands you would name, an angel network, two accelerators and a government fund all rank above the first marquee VC. Government is a top-five force. Whole categories drew almost nothing. And the companies that raised the most money are not the ones that pulled the most investors, which is the contrast we kept coming back to.

Capital & Conviction is eight pages, free, and behind no email gate. Download below.